Elizabeth Iorns
Statistics and Probability · 2010–2014
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 13 citations into it
Whom Elizabeth Iorns trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Elizabeth Iorns's perspective
Ordered by how strongly the researchers Elizabeth Iorns trusts endorse each paper. Same corpus, a different order for every researcher.
- Registered Reports A Method to Increase the Credibility of Published Results
- Rescuing US biomedical research from its systemic flaws (Proceedings of the National Academy of Sciences of the United States of America)
- Recommendations for Increasing Replicability in Psychology †
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer (Journal of the National Cancer Institute)
- The RSK family of kinases: emerging roles in cellular signalling (Nature reviews. Molecular cell biology)
- Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. (Journal of Clinical Oncology)
- Believe it or not: how much can we rely on published data on potential drug targets? (Nature reviews. Drug discovery)
- Inference by eye: confidence intervals and how to read pictures of data. (American Psychologist)
- Sample size planning for statistical power and accuracy in parameter estimation. (Annual Review of Psychology)
- Conducting Meta-Analyses in R with the metafor Package
Their papers
- An open investigation of the reproducibility of cancer biology research (2014) — 272 citations
- FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer (2010) — 695 citations